CLGN logo

CLGN Free Cash Flow

Annual FCF

-$3.72 M
+$11.30 M+75.24%

December 31, 2023

Summary

Performance

1-Year Change

+75.24%

3-Year Change

+25.21%

5-Year Change

-81.41%

15-Year Change

+27.02%

CLGN Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

75.16%
CLGN annual free cash flow is higher than 75.16% of companies in Healthcare sector

High & Low

All-time High

$912.00 K
CLGN annual free cash flow is currently -507.57% below its historical high of $912.00 thousand

3-Year Low

-$15.01 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CLGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 4, 2025
CLGN next annual earnings announcement is scheduled for Apr 4, 2025

OtherCLGNcash flowmetrics:

Annual CFO

-$2.76 M
CLGN annual cash flow from operations is -$2.76 million

Annual CFF

$1.11 M
CLGN annual cash flow from financing activities is $1.11 million

Annual CFI

-$1.16 M
CLGN annual cash flow from investing activities is -$1.16 million

Annual CAPEX

$954.00 K
CLGN annual capital expenditures is $954.00 thousand

Quarterly FCF

-$3.59 M
+$542.00 K+13.12%

September 30, 2024

Summary

Performance

3-Month Change

+13.12%

1-Year Change

-154.92%

3-Year Change

-154.92%

5-Year Change

-154.92%

CLGN Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.01%
CLGN quarterly free cash flow is higher than 52.01% of companies in Healthcare sector

High & Low

All-time High

$10.94 M
CLGN quarterly free cash flow is currently -132.80% below its historical high of $10.94 million

3-Year Low

-$4.34 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CLGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 4, 2025
CLGN next earnings announcement is scheduled for Apr 4, 2025

OtherCLGNcash flowmetrics:

Quarterly CFO

-$3.45 M
CLGN quarterly cash flow from operations is -$3.45 million

Quarterly CFF

$0.00
CLGN quarterly cash flow from financing activities is $0.00

Quarterly CFI

-$140.00 K
CLGN quarterly cash flow from investing activities is -$140.00 thousand

Quarterly CAPEX

$140.00 K
CLGN quarterly capital expenditures is $140.00 thousand

TTM FCF

-$13.63 M
-$10.12 M-288.68%

September 30, 2024

Summary

Performance

3-Month Change

-288.68%

1-Year Change

-184.31%

3-Year Change

-184.31%

5-Year Change

-184.31%

CLGN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.86%
CLGN TTM free cash flow is higher than 55.86% of companies in Healthcare sector

High & Low

All-time High

$8.64 M
CLGN TTM free cash flow is currently -257.74% below its historical high of $8.64 million

3-Year Low

-$15.10 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CLGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 4, 2025
CLGN next earnings announcement is scheduled for Apr 4, 2025

OtherCLGNcash flowmetrics:

TTM CFO

-$12.97 M
CLGN TTM cash flow from operations is -$12.97 million

TTM CFF

$9000.00
CLGN TTM cash flow from financing activities is $9000.00

TTM CFI

-$853.00 K
CLGN TTM cash flow from investing activities is -$853.00 thousand

TTM CAPEX

$653.00 K
CLGN TTM capital expenditures is $653.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$3.72 M
CLGN annual free cash flow is -$3.72 million

Annual CFO

-$2.76 M
CLGN annual cash flow from operations is -$2.76 million

Annual CAPEX

$954.00 K
CLGN annual capital expenditures is $954.00 thousand

CLGN Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+75.2%-154.9%-184.3%
3 y3 years+25.2%-154.9%-184.3%
5 y5 years-81.4%-154.9%-184.3%

CLGN Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-507.6%+75.2%-154.9%+17.4%-1594.2%+9.7%
5 y5-year-507.6%+75.2%-132.8%+17.4%-257.7%+9.7%
alltimeall time-507.6%+75.2%-132.8%+17.4%-257.7%+9.7%

CollPlant Biotechnologies Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.59 M(-13.1%)
-$13.63 M(+288.7%)
Jun 2024
-
-$4.13 M(+23.8%)
-$3.51 M(+1.4%)
Mar 2024
-
-$3.33 M(+29.6%)
-$3.46 M(-7.0%)
Dec 2023
-$3.72 M(-75.2%)
-$2.57 M(-139.4%)
-$3.72 M(-22.4%)
Sep 2023
-
$6.53 M(-260.1%)
-$4.79 M(-67.7%)
Jun 2023
-
-$4.08 M(+13.5%)
-$14.83 M(-1.7%)
Mar 2023
-
-$3.60 M(-1.5%)
-$15.10 M(+0.5%)
Dec 2022
-$15.01 M(-1746.3%)
-$3.65 M(+4.1%)
-$15.01 M(+5.1%)
Sep 2022
-
-$3.51 M(-19.2%)
-$14.29 M(+0.4%)
Jun 2022
-
-$4.34 M(+23.6%)
-$14.24 M(+5.1%)
Mar 2022
-
-$3.51 M(+20.1%)
-$13.54 M(-1584.8%)
Dec 2021
$912.00 K(-118.4%)
-
-
Dec 2021
-
-$2.93 M(-15.2%)
$912.00 K(-56.6%)
Sep 2021
-
-$3.45 M(-5.4%)
$2.10 M(-69.6%)
Jun 2021
-
-$3.65 M(-133.3%)
$6.91 M(-20.0%)
Mar 2021
-
$10.94 M(-729.4%)
$8.64 M(-273.8%)
Dec 2020
-$4.97 M(-30.9%)
-
-
Dec 2020
-
-$1.74 M(-228.1%)
-$4.97 M(-4.6%)
Sep 2020
-
$1.36 M(-170.7%)
-$5.21 M(-34.9%)
Jun 2020
-
-$1.92 M(-28.1%)
-$8.00 M(-2.4%)
Mar 2020
-
-$2.67 M(+35.1%)
-$8.19 M(+13.9%)
Dec 2019
-$7.19 M
-
-
Dec 2019
-
-$1.98 M(+37.9%)
-$7.19 M(+241.6%)
Sep 2019
-
-$1.43 M(-32.2%)
-$2.11 M(+13.7%)
Jun 2019
-
-$2.12 M(+26.6%)
-$1.85 M(-10.0%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$1.67 M(-153.7%)
-$2.06 M(+0.4%)
Dec 2018
-$2.05 M(-59.8%)
-
-
Dec 2018
-
$3.11 M(-363.7%)
-$2.05 M(-69.1%)
Sep 2018
-
-$1.18 M(-49.1%)
-$6.62 M(+4.1%)
Jun 2018
-
-$2.32 M(+39.7%)
-$6.36 M(+24.8%)
Mar 2018
-
-$1.66 M(+13.5%)
-$5.10 M(+0.0%)
Dec 2017
-$5.09 M(-1.3%)
-
-
Dec 2017
-
-$1.46 M(+59.7%)
-$5.09 M(+10.2%)
Sep 2017
-
-$916.50 K(-13.0%)
-$4.62 M(+0.1%)
Jun 2017
-
-$1.05 M(-36.5%)
-$4.62 M(-7.3%)
Mar 2017
-
-$1.66 M(+67.1%)
-$4.98 M(-3.5%)
Dec 2016
-$5.16 M(+26.8%)
-
-
Dec 2016
-
-$992.60 K(+9.1%)
-$5.16 M(+2.1%)
Sep 2016
-
-$909.70 K(-35.8%)
-$5.05 M(+6.6%)
Jun 2016
-
-$1.42 M(-23.0%)
-$4.74 M(-2.5%)
Mar 2016
-
-$1.84 M(+108.2%)
-$4.86 M(+19.4%)
Dec 2015
-$4.07 M(+19.2%)
-
-
Dec 2015
-
-$884.10 K(+48.4%)
-$4.07 M(+5.0%)
Sep 2015
-
-$595.80 K(-61.3%)
-$3.88 M(+18.2%)
Jun 2015
-
-$1.54 M(+46.8%)
-$3.28 M(+208.5%)
Mar 2015
-
-$1.05 M(+51.8%)
-$1.06 M(+7495.0%)
Dec 2014
-$3.41 M(-13.3%)
-
-
Dec 2014
-
-$691.20 K(-202.1%)
-$14.00 K(-102.1%)
Jun 2014
-
$677.20 K
$677.20 K
Dec 2013
-$3.94 M(-1.1%)
-
-
Dec 2012
-$3.98 M
-
-

FAQ

  • What is CollPlant Biotechnologies annual free cash flow?
  • What is the all time high annual FCF for CollPlant Biotechnologies?
  • What is CollPlant Biotechnologies annual FCF year-on-year change?
  • What is CollPlant Biotechnologies quarterly free cash flow?
  • What is the all time high quarterly FCF for CollPlant Biotechnologies?
  • What is CollPlant Biotechnologies quarterly FCF year-on-year change?
  • What is CollPlant Biotechnologies TTM free cash flow?
  • What is the all time high TTM FCF for CollPlant Biotechnologies?
  • What is CollPlant Biotechnologies TTM FCF year-on-year change?

What is CollPlant Biotechnologies annual free cash flow?

The current annual FCF of CLGN is -$3.72 M

What is the all time high annual FCF for CollPlant Biotechnologies?

CollPlant Biotechnologies all-time high annual free cash flow is $912.00 K

What is CollPlant Biotechnologies annual FCF year-on-year change?

Over the past year, CLGN annual free cash flow has changed by +$11.30 M (+75.24%)

What is CollPlant Biotechnologies quarterly free cash flow?

The current quarterly FCF of CLGN is -$3.59 M

What is the all time high quarterly FCF for CollPlant Biotechnologies?

CollPlant Biotechnologies all-time high quarterly free cash flow is $10.94 M

What is CollPlant Biotechnologies quarterly FCF year-on-year change?

Over the past year, CLGN quarterly free cash flow has changed by -$10.12 M (-154.92%)

What is CollPlant Biotechnologies TTM free cash flow?

The current TTM FCF of CLGN is -$13.63 M

What is the all time high TTM FCF for CollPlant Biotechnologies?

CollPlant Biotechnologies all-time high TTM free cash flow is $8.64 M

What is CollPlant Biotechnologies TTM FCF year-on-year change?

Over the past year, CLGN TTM free cash flow has changed by -$8.83 M (-184.31%)